Stay updated with breaking news from Minnau Kaikkonen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
University of Virginia School of Medicine scientists have found important answers about strokes, heart attacks and cardiovascular diseases by probing the biological glue our bodies create to protect us from those deadly dangers.
University of Virginia researchers and their collaborators have identified genes that play key roles in the development of coronary artery disease, the No. 1 cause of death worldwide.
Researchers at the University of Eastern Finland have uncovered potential mechanisms by which microRNAs (miRNA) drive atherogenesis in a cell-type-specific manner. Published in the Arteriosclerosis, Thrombosis, and Vascular Biology journal, the study provides novel insight into the miRNA profiles of the main cell types involved in atherosclerosis.
E-Mail IMAGE: Researcher Mete Civelek, PhD, of the University of Virginia School of Medicine's Department of Biomedical Engineering and UVA's Center for Public Health Genomics. view more Credit: Courtesy Civelek lab Researchers at the University of Virginia have shed light on how our genes affect our risk for coronary artery disease, the most common form of heart disease. In addition to identifying gene variants that influence risk, they found that one gene in particular appears to have a protective effect. Doctors may be able to use the findings to identify people at high risk ...
UVA researchers identify genes that influence risk for common form of heart disease Dec 10 2020 Researchers at the University of Virginia have shed light on how our genes affect our risk for coronary artery disease, the most common form of heart disease. In addition to identifying gene variants that influence risk, they found that one gene in particular appears to have a protective effect. Doctors may be able to use the findings to identify people at high risk and to develop better treatments and preventative interventions. Current drugs for coronary artery disease treat the risk factors, suc...